mitochondrial K + ATP channels (mitoK + ATP ) and the production of reactive oxygen species (ROS). [1] [2] [3] [4] [5] [6] We previously simulated ischaemia by cyanide-induced metabolic inhibition (MI). 4, 7 Cyanide inactivates cytochrome c oxidase in complex IV of the mitochondrial electron transport chain (ETC), resulting in ATP depletion and ROS formation (Fig. 1) . 8 9 In contrast, hypoxia is associated with a reduction in O 2 concentration and thereby prevents complex IV from donating electrons, finally leading to ATP depletion. Furthermore, hypoxia coincides with more mitochondrial nitric oxide (NO), which also inhibits complex IV and reduces mitochondrial O 2 consumption, the latter resulting in superoxide generation. 10 11 Finally, hypoxia, but not MI, is followed by reoxygenation, which may cause additional cardiac injury. 12 It has already been shown that the type of preconditioning stimulus determines the relative contribution of distinct signalling molecules in the cardioprotective process 13 and thus it may be possible that the type of metabolic deprivation induces variation in the signal transduction pathways involved in sevoflurane-induced cardioprotection.
We therefore investigated whether two different causes of ischaemic injury, that is MI and hypoxia, alter the relative contribution of PKC, mitoK + ATP and ROS in the signal transduction pathways for sevoflurane-induced cardioprotection in isolated right ventricular trabeculae of the rat. 4 
Materials and methods

Animals
Male Wistar rats (250-400 g, Harlan, The Netherlands) were used according to the Institutional Animal Care and Use Committee of the VU University Medical Center. Rats were anaesthetized with sodium pentobarbital (80 mg kg À1 , i.p., Nembutal Ò , Sanofi Sante BV) and i.v. heparinized with 1000 units (Leo Pharma, Breda, The Netherlands). Subsequently, the heart was quickly removed and perfused through the aorta with Tyrode buffer (120 mM NaCl, 1.22 mM MgSO 4 .7H 2 0, 1.99 mM NaH 2 PO 4 , 27.0 mM NaHCO 3 , 5.0 mM KCl, 1 mM CaCl 2 and 10 mM glucose; 95% O 2 /5% CO 2 , pH 7.4). The myocardium was protected during dissection by adding 30 mM 2,3-butanedione monoxime and 15 mM KCl to the buffer solution.
14 A suitable right ventricular trabecula (length 2-5 mm, diameter <0.2 mm) was carefully dissected. 15 
Experimental set-up
The muscle was mounted between a force-transducer (AE801, SensoNor, Norway) and a micromanipulator in an airtight organ bath. After mounting, superfusion was started with normal Tyrode buffer at 27 C (2 ml min À1 ), and trabeculae were stimulated (5 ms duration, stimulation frequency 0.5 Hz). Subsequently, trabeculae were stretched until passive force (F pas ) was approximately 8% of developed force. 16 After 40 min of stabilization, the stimulation frequency and temperature were decreased to 0.2 Hz and 24 C, respectively, followed by another 20 min of stabilization. After this period, initial developed force of contraction (F dev,start ) and maximal force (F max,start ), as determined by a post-extrasystolic potentiation protocol (PESP), were recorded. PESP determines the contractile reserve of trabeculae by maximal Ca 2+ filling of the sarcoplasmic reticulum. 17 Trabeculae failing to stabilize, failing to show PESP or spontaneously contracting trabeculae were excluded. Figure 2 shows the experimental groups to which trabeculae were assigned. Trabeculae (except for time controls; n=5) were either subjected to a period of hypoxia (HYP; n=5) or metabolic inhibition (MI; n=5). During hypoxia, trabeculae were superfused with hypoxic Tyrode (95% N 2 and 5% CO 2 , PO 2 <4 mm Hg), whereas during MI muscles were superfused with buffer containing 2 mM sodium cyanide. During hypoxia or MI, glucose was omitted from the buffer and the stimulation frequency was increased to 1 Hz. Shortly after starting hypoxia or MI, contractile force decreased to zero followed by an increase in F pas . When F pas increased to 50% of F max,start , trabeculae were subjected to another 40 min of hypoxia or to 30 min of MI. Subsequently, muscles were perfused with normal oxygenated buffer for 60 min to allow contractile recovery. The recovery of F dev (F dev,rec ), time to peak, time to half relaxation, and rate of contraction (+dFdt) and relaxation (ÀdFdt) were determined and expressed as a percentage of the initial values during the start of experiment. Except for time and inhibitor control experiments, trabeculae were preconditioned for 15 min with normal Tyrode saturated with 3.8 vol% vaporized sevoflurane (Sevorane Ò , Abbott) 30 min before hypoxia or MI. The volume percentage of sevoflurane in the gas phase above the Tyrode was continuously monitored by a calibrated infrared anaesthetic monitor (Capnomac Ultima, Datex, Helsinki, Finland). After washout of sevoflurane, trabeculae were superfused for 15 min with normal Tyrode until hypoxia or MI.
Experimental protocol
In the inhibitor groups, trabeculae were additionally superfused with either the PKC-catalytic site inhibitor chelerythrine (CHEL; 6 mM; n=5; Sigma-Aldrich), the mitoK + ATP channel blocker 5-hydroxydecanoate (5-HD; 100 mM; n=5; Sigma-Aldrich) or the ROS-scavenger n-(2-mercaptopropionyl)-glycine (MPG; 300 mM; n=5; Sigma-Aldrich) 10 min before preconditioning until the washout period before hypoxia or MI (see Fig. 2 ). The effects of inhibitors alone on F dev,rec were studied in separate inhibitor control experiments for both conditions of metabolic deprivation.
Determination of necrosis and apoptosis
The extent of necrosis and apoptosis was evaluated by cell morphology studies using haematoxylin-eosin staining, histochemical staining of myoglobin and TdT-mediated dUTP nick-end labelling (TUNEL) staining for evaluation of DNA fragmentation. All trabeculae subjected to these measurements were immediately embedded in gelatin after 60 min of recovery after either hypoxia or MI, frozen in liquid nitrogen and stored at À80 C until use. Cross-sections (5 mm) were histochemically stained for myoglobin as previously described by Lee-de Groot and colleagues. 18 In a separate set, TUNEL staining was performed with the Dead End Fluorometric TUNEL labelling kit (Promega). These sections were counterstained with 10% (v/v) wheat germ agglutinin (W-7024, Molecular Probes) to provide sarcolemmal staining and mounted on glass cover slips using 4 0 ,6-diamidino-2-phenylindole (DAPI)-containing medium (H1200, Vectashield, Vector Laboratories, Burlingame, USA) to stain the nuclei.
Sections stained for haematoxylin-eosin and TUNEL were analysed by digital imaging fluorescence microscopy equipped on a ZEISS Axiovert 200 MarianasÔ inverted digital imaging microscopy workstation. Images were recorded with a cooled CCD camera [Cooke Sensicam (Cooke Co., Tonawanda, NY), 1280·1024 pixels]. The digital imaging microscopy workstation was under full software control [SlideBookÔ software version 3.11 (Intelligent Imaging Innovations, Denver, CO)].
Statistical analysis
The sample size of each experimental group was five, except the inhibitor control groups (n=4). Data were tested for normal distribution and one-way ANOVA followed by a Tukey post hoc analysis or a Student's t-test, when appropriate, was performed to determine differences between the experimental groups. A P-value <0.05 was considered to reflect a significant difference. All values are given as mean (SEM).
Results
General characteristics
Time to rigor development was similar in both the HYP and MI group and was only minimally (not significantly) affected by sevoflurane pretreatment or the inhibitors (Table 1 ). In the time control group, F dev was reduced after 3 h to 80 (9)%. Figure 3 Determination of necrosis and apoptosis Figure 5 shows markers of apoptosis and necrosis in embedded trabeculae. There was no difference between the experimental groups in cell morphology as shown by (6) haematoxylin-eosin staining ( 
Discussion
We have demonstrated that the relative contribution of three common signalling molecules in sevoflurane-induced cardioprotection is not dependent on the type of applied ischaemic stimulus. PKC activation, opening of mitoK + ATP channels and ROS are essential in conferring sevoflurane-induced protection against metabolic deprivation as induced by hypoxia and metabolic inhibition (MI) through cyanide. Furthermore, trabeculae subjected to hypoxia or MI showed no markers for apoptosis and necrosis, indicating cardiac contractile dysfunction after recovery after hypoxia or MI as a result of altered Ca 2+ handling and/or myofilament Ca 2+ sensitivity rather than loss of cardiomyocytes.
Cyanide has frequently been used to model hypoxia. Recent studies show that clear differences exist in physiological responses to chemical anoxia and hypoxia. 19 20 In addition isolated cardiomyocytes subjected to cyanide became necrotic and had more LDH-release compared with cells subjected to hypoxia. 21 Differences between hypoxia and MI may rely on (i) distinct sources of ROS formation such as xanthine dehydrogenase-oxidase, myoglobin or NADPH-oxidase, as cyanide predominantly inhibits complex IV; (ii) higher concentrations of ROS formation during MI as high concentration of O 2 are present as a result of inhibition of complex IV; and (iii) a different modulation of the O 2 -dependent regulation of mitochondrial redox signalling by NO during hypoxia (see also Fig. 1 ). 11 Thus, the contribution of ROS and NO signalling pathways is different in hypoxia and MI-induced ischaemic injury.
It has been demonstrated that the production of ROS during sevoflurane preconditioning involves inhibition of the mitochondrial ETC. 22 Interestingly, Riess and colleagues 23 recently showed that inhibition of sevofluraneinduced preconditioning with either ROS-or NOscavengers was associated with reduced attenuation of the mitochondrial ETC. This suggests that sevoflurane-induced inhibition of the ETC is mediated via ROS and NO and therefore implies that differences in ROS and NO signalling between hypoxia and MI may account for variation in the cardioprotective signalling induced by volatile anaesthetics. However, we demonstrated that in both hypoxia and MI, preconditioning with sevoflurane equally preserves contractile function of myocardial tissue. Moreover, in both models PKC, mitoK + ATP and ROS are likewise involved. This shows indirectly that the mechanism of preconditioning with sevoflurane involves mainly the protection against adverse effects of mitochondrial ETC inhibition during ischaemia, that is the generation of ROS, ATP-depletion and Ca 2+ overload. It is important to note that the recovery of preconditioned trabeculae treated with the ROS-scavenger MPG was different in the hypoxia and MI group (Fig. 3) . The underlying mechanism cannot be explained from these data, but it may suggest differences in the actual mechanism of protection against oxidative stress as a result of hypoxia or metabolic inhibition exist despite equal involvement of the signal transduction molecules in sevoflurane-induced cardioprotective signalling. Nevertheless, this remains speculative at this time and should be addressed in future studies.
Recently, it has been demonstrated that preconditioning with sevoflurane improved mitochondrial function during hypoxia, as demonstrated by increased ATP synthesis and reduced ROS formation in addition to a reduced Ca 2+ load. 3 6 This protection depended on opening of the mitoK + ATP channels. Akao and colleagues 24 showed that hypoxia-induced ROS production results in a loss of mitochondrial membrane potential (DC m ), which serves as an indicator of mitochondrial function. This loss of DC m was attenuated by specific mitochondrial K + channel openers, confirming the importance of mitochondrial integrity for the prevention of cellular injury. Similarly, volatile anaesthetics augment the open probability of mitoK + ATP channels via a PKC-dependent pathway, 25 suggesting that they might preserve mitochondrial function via PKC and mitoK + ATP channels. In our study, trabeculae subjected to either hypoxia or MI did not show increases in markers for necrosis or apoptosis. However, after 60 min of recovery after MI or hypoxia, apoptotic and necrotic markers may not yet be visible. This was also found in other studies showing that 60 min of ischaemia or less is not sufficient to induce significant apoptotic or necrotic characteristics. 26 Our data suggest that in both models of metabolic deprivation the reduction of active force development might be provoked by postischaemic cardiomyocyte contractile dysfunction because of altered Ca 2+ handling and/or Ca 2+ sensitivity, rather than by a loss of cardiomyocytes. Currently, several mechanisms have been proposed to be involved in ischaemic cardiomyocyte dysfunction, such as the generation of ROS and Ca 2+ overload, both leading to damage of proteins involved in either contraction or Ca 2+ homeostasis. 27 Interestingly, our data suggest that sevoflurane might protect SR function as demonstrated by alterations in the rate of contraction (+dFdt) and relaxation (ÀdFdt). Sevoflurane preserves the +dFdt and ÀdFdt compared with hypoxia alone, indicating preserved Ca 2+ handling and Ca 2+ availability. 28 These data correspond to Ca 2+ measurements performed in isolated trabecula, showing that the Ca 2+ re-uptake capacity of the SR was improved in pharmacologically preconditioned trabeculae subjected to MI. 7 In this study we used isolated right ventricular trabeculae to elucidate mechanisms of sevoflurane-induced preconditioning. We extensively applied this well-defined model for intracellular signalling and for functional studies in several previous publications.
4 7 16 However several limitations should be taken into account in the interpretation of the present results. Experiments were performed at 24 C to maintain a stable preparation over several hours and to prevent oxygen limitation. These relatively hypothermic conditions may affect (cardioprotective) signalling processes. With regard to the production of ROS, the effect of hypothermia is difficult to predict, as reduced and increased production of ROS have been reported. 29 30 Additionally, activation of other signalling molecules, such as PKC and mitoK + ATP -channels, has been demonstrated to occur under hypothermic conditions. 31 32 Furthermore, this study depends on the specificity of the pharmacological inhibitors used. Chelerythrine, MPG and 5-HD are commonly used inhibitors in preconditioning studies and the concentrations used are comparable with existing literature.
In conclusion, our study shows that hypoxia and MI, are both suitable to study the cardioprotective properties of sevoflurane. Although hypoxic injury may be more relevant to the clinical situation, the effects of cyanide on complex IV of the mitochondrial ETC closely resembles carbon monoxide poisoning. 33 The activated intracellular signal transduction pathway involved in sevoflurane-induced cardioprotection is not dependent on the applied ischaemic stimulus. This suggests that a common trigger, such as ROS production, may be responsible for the onset of the protective process in cardiomyocytes.
reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism. Anesthesiology 2003; 98: 1155-63 4 de Ruijter W, Musters RJP, Boer C, Stienen GJM, Simonides WS, de Lange JJ. The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K
